Stromal biomarker-based framework for identifying pMMR/MSS and dMMR/MSI colorectal cancers with poor outcomes and limited benefit from immunotherapy.
Overview & Synopsis
Open access biomedical research article published in Gut.
Indexed from repository: PubMed Central
(
pmc.ncbi.nlm.nih.gov)
Keyboard Shortcuts:
← / → for pages • + / - for zoom • 0 to fit width
Powered by Mozilla PDF.js v3.11
Document Information
| Document Title | Stromal biomarker-based framework for identifying pMMR/MSS and dMMR/MSI colorectal cancers with poor outcomes and limited benefit from immunotherapy. |
|---|---|
| Author / Organization | Iglesias Coma M, Badia-Ramentol J, Martinez-Ciarpaglini C, Linares J, Tarazona N, Mulet-Margalef N, Tornero-Piñero P, Sallent-Aragay A, Recort-Bascuas A, Gibert J, Sant-Albors M, Tauriello DVF, Cruz-Moral M, Carreras-Gallardo M, Sancho E, Morral Martinez C, Garrido M, Mozo JLM, Cervantes A, Montagut C, Batlle E, Calon A |
| Subject & Discipline | Gut |
| Categories | Medicine & Health |
| Publication Year | 2026 |
| License / Rights | Open Access / Creative Commons |
| Resource Verification | Listed PDF (Verification Pending) |
| Original Host Website |
PubMed Central
(pmc.ncbi.nlm.nih.gov)
|
| File Format | application/pdf (Portable Document Format) |
| Language | EN |
| Catalog ID | DOC-46300 |
| Original Source Link | Visit Source Page on pmc.ncbi.nlm.nih.gov » |